Kevin Horgan in

Kevin Horgan

Login to view DISC.
Head of Research And Development at Melius MicroBiomics
📍 Philadelphia, Pennsylvania, United States

Kevin Horgan is a physician-scientist and the Head of Research and Development at Melius MicroBiomics. He has extensive experience leading drug development across multiple therapeutic areas, with a distinct expertise in the microbiome, AI, and diagnostics. He studied Medicine and Physiology at University College Cork.

Outside of his direct professional roles, Kevin is an avid reader who enjoys the unique insights of columnists like Gillian Tett in the Financial Times. He follows developments at major pharmaceutical companies like Eli Lilly and academic institutions such as the University of Pennsylvania.

Unique fact: He led the clinical development of Emend, the first NK1 receptor antagonist approved for chemotherapy-induced nausea and vomiting.

Read the full overview →
Experience
14 Years
Current Role
Head of Research And Development
Job Level
Mid-senior
Location
Philadelphia, Pennsylvania, United States
Personality Overview

How Kevin shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Kevin cares about

Microbiome Medicines
His company, Melius MicroBiomics, focuses on genetically engineering microbial medicine. He actively posts about the microbiome's potential to treat conditions like ulcerative colitis.
AI in Biomedicine
A core focus of his career is applying AI to transform biomedical research and enable precision medicine, holding advisory roles at AI-focused companies like Artificial Genius Inc.
+5 more topics Login to view topics
Career

Work history

5-2025
Head of Research And Development
Melius MicroBiomics
12-2024
Senior Advisor, Biology and Medicine
Artificial Genius Inc.
10-2011
Medical Advisor
Liquid Biosciences - formerly Emerald Logic
4-2024 - 4-2025
Director
Alector
5-2023 - 3-2024
Co-Founder
Stealth Startup - Biotech
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1976 - 1984
Medicine & Physiology
University College Cork
Education details unavailable
Crescent College
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Daniel Hogan
Daniel Hogan
Bagger
Schnuck Markets, Inc.
 Kevin Renner
Kevin Renner
Digital Marketing & Loyalty Lead
Schnuck Markets, Inc.
 Dwight Smith
Dwight Smith
Registered Respiratory Therapist
CommonSpirit Health/St. LUKES Health
 Michael Wait
Michael Wait
Sr. Director Infrastructure & Application Development
Schnuck Markets, Inc.
Unlock the full playbookSee exactly how to sell to Kevin. Free, 10 seconds.